tiprankstipranks
Ginkgo Bioworks Holdings (MX:DNA)
:DNA
Mexico Market
DNA
Ginkgo Bioworks Holdings
RESEARCH TOOLSreports

Ginkgo Bioworks Holdings (DNA) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

DNA Analyst Ratings

Hold
2Ratings
Hold
1 Buy
0 Hold
1 Sell
Based on 2 analysts giving stock ratings to
Ginkgo
Bioworks Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DNA Stock 12 Month Forecast

Average Price Target

$209.21
▲(23.06% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Ginkgo Bioworks Holdings in the last 3 months. The average price target is $209.21 with a high forecast of $209.21 and a low forecast of $209.21. The average price target represents a 23.06% change from the last price of $170.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"149":"$149","290":"$290","184.25":"$184.3","219.5":"$219.5","254.75":"$254.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":209.20866816,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$209.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":209.20866816,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$209.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":209.20866816,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$209.21</span>\n  </div></div>","useHTML":true}}],"tickPositions":[149,184.25,219.5,254.75,290],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150,154.55451293538462,159.10902587076924,163.66353880615384,168.21805174153846,172.77256467692308,177.3270776123077,181.88159054769233,186.43610348307692,190.99061641846154,195.54512935384616,200.09964228923076,204.6541552246154,{"y":209.20866816,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150,154.55451293538462,159.10902587076924,163.66353880615384,168.21805174153846,172.77256467692308,177.3270776123077,181.88159054769233,186.43610348307692,190.99061641846154,195.54512935384616,200.09964228923076,204.6541552246154,{"y":209.20866816,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,150,154.55451293538462,159.10902587076924,163.66353880615384,168.21805174153846,172.77256467692308,177.3270776123077,181.88159054769233,186.43610348307692,190.99061641846154,195.54512935384616,200.09964228923076,204.6541552246154,{"y":209.20866816,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":210,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":237,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":237,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":237,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":289,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":176.13,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":176.13,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":163,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":163,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 48, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 22</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":150,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 65, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 22</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":150,"date":1782864000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 76, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$209.21Average Price Target$209.21Lowest Price Target$209.21
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:DNA
Matt Larew
William Blair
William Blair
―
Sell
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
TD Cowen Analyst forecast on MX:DNA
Brendan Smith
TD Cowen
TD Cowen
$209.81
Buy
23.42%
Upside
Reiterated
05/07/26
Ginkgo Bioworks Reaffirmed at Buy as Strategic Refocus, Cost Cuts and New Partnerships Support Unchanged $12 Price Target
BTIG Analyst forecast on MX:DNA
Mark Massaro
BTIG
BTIG
$157.36→$87.42
Sell
-48.58%
Downside
Assigned
03/12/26
Analysts Conflicted on These Healthcare Names: Valneva (NASDAQ: VALN), Biogen (NASDAQ: BIIB) and Ginkgo Bioworks Holdings (NYSE: DNA)
Bank of America Securities Analyst forecast on MX:DNA
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
―
Sell
―
Reiterated
11/07/25
Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:DNA
Matt Larew
William Blair
William Blair
―
Sell
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
TD Cowen Analyst forecast on MX:DNA
Brendan Smith
TD Cowen
TD Cowen
$209.81
Buy
23.42%
Upside
Reiterated
05/07/26
Ginkgo Bioworks Reaffirmed at Buy as Strategic Refocus, Cost Cuts and New Partnerships Support Unchanged $12 Price Target
BTIG Analyst forecast on MX:DNA
Mark Massaro
BTIG
BTIG
$157.36→$87.42
Sell
-48.58%
Downside
Assigned
03/12/26
Analysts Conflicted on These Healthcare Names: Valneva (NASDAQ: VALN), Biogen (NASDAQ: BIIB) and Ginkgo Bioworks Holdings (NYSE: DNA)
Bank of America Securities Analyst forecast on MX:DNA
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
―
Sell
―
Reiterated
11/07/25
Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ginkgo Bioworks Holdings

3 Months
Mark MassaroBTIG
Success Rate
9/21 ratings generated profit
43%
Average Return
-6.44%
assigned a sell rating 5 months ago
Copying Mark Massaro's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -6.44% per trade.
1 Year
Matt LarewWilliam Blair
Success Rate
4/10 ratings generated profit
40%
Average Return
-12.73%
reiterated a sell rating 3 months ago
Copying Matt Larew's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -12.73% per trade.
2 Years
Matt LarewWilliam Blair
Success Rate
6/10 ratings generated profit
60%
Average Return
-8.99%
reiterated a sell rating 3 months ago
Copying Matt Larew's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of -8.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DNA Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
2
1
1
1
1
Hold
24
37
48
65
76
Sell
7
19
22
22
17
Strong Sell
0
0
0
0
0
total
33
57
71
88
94
In the current month, DNA has received 1 Buy Ratings, 76 Hold Ratings, and 17 Sell Ratings. DNA average Analyst price target in the past 3 months is 209.21.
Each month's total comprises the sum of three months' worth of ratings.

DNA Financial Forecast

DNA Earnings Forecast

Next quarter’s earnings estimate for DNA is -$15.60 with a range of -$19.00 to -$12.20. The previous quarter’s EPS was -$24.23. DNA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year DNA has Performed in-line its overall industry.
Next quarter’s earnings estimate for DNA is -$15.60 with a range of -$19.00 to -$12.20. The previous quarter’s EPS was -$24.23. DNA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year DNA has Performed in-line its overall industry.

DNA Sales Forecast

Next quarter’s sales forecast for DNA is $419.29M with a range of $413.19M to $425.39M. The previous quarter’s sales results were $339.51M. DNA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year DNA has Performed in-line its overall industry.
Next quarter’s sales forecast for DNA is $419.29M with a range of $413.19M to $425.39M. The previous quarter’s sales results were $339.51M. DNA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year DNA has Performed in-line its overall industry.

DNA Stock Forecast FAQ

What is MX:DNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Ginkgo Bioworks Holdings’s 12-month average price target is 209.21.
    What is MX:DNA’s upside potential, based on the analysts’ average price target?
    Ginkgo Bioworks Holdings has 23.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Ginkgo Bioworks Holdings a Buy, Sell or Hold?
          Ginkgo Bioworks Holdings has a consensus rating of Hold, which is based on 1 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Ginkgo Bioworks Holdings’s share price target?
            The average share price target for Ginkgo Bioworks Holdings is 209.21. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $209.21 ,and the lowest forecast is $209.21. The average share price target represents 23.06% Increase from the current price of $170.
              What do analysts say about Ginkgo Bioworks Holdings?
              Ginkgo Bioworks Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Ginkgo Bioworks Holdings?
                To buy shares of MX:DNA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.